Lexeo Therapeutics (LXEO) Financials: Revenue & Earnings
LXEO$3.17+0.04 +1.44%
$260.63M
Market Cap
—
P/E
—
Forward P/E
—
Score
Lexeo Therapeutics (LXEO) Financials: Revenue & Earnings
LXEO price $3.17 +0.04 +1.44%
- Ticker
- LXEO
- Price
- $3.17
- Change
- +0.04 +1.44%
- Market cap ?
- $260.63M
- Sector
- Healthcare
- Industry
- Biotechnology
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic…
Earnings and financials
Lexeo Therapeutics, Inc. Common Stock (LXEO) trades at $3.17, with a market cap of $260.63M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn